Prediction of prolonged mechanical ventilation in the intensive care unit via machine learning: a COVID-19 perspective.

Publication date: Dec 04, 2024

Early recognition of risk factors for prolonged mechanical ventilation (PMV) could allow for early clinical interventions, prevention of secondary complications such as nosocomial infections, and effective triage of hospital resources. This study tested the hypothesis that an ensemble machine learning (ML) analysis of clinical data at time of intubation could identify patients at risk of PMV, using a COVID-19 dataset to classify patients into PMV (> 14 days) and non-PMV (≤ 14 days) groups. While several factors are known to cause PMV, including acid-base, weakness, and delirium, lesser-utilized but routinely measured parameters such as platelet count, glucose levels and fevers may also be relevant. Patient data from a single University Hospital were analyzed via the ML workflow to predict patients at risk of PMV and identify key clinical markers. Model performance was evaluated on a chronologically distinct cohort. The ML workflow identified patients at risk of PMV with AUROC=0. 960 (F1 = 0. 935) and AUROC=0. 804 (F1 = 0. 800). Top key features for classification included glucose, platelet count, temperature, LVEF, bicarbonate (arterial blood gas), and BMI. Data analysis at intubation time via the proposed workflow offers the potential to accurately predict patients at risk of PMV, with the goal to improve patient management and triage of hospital resources.

Open Access PDF

Concepts Keywords
F1 Aged
Fevers COVID-19
Glucose COVID-19
Hospital Female
Humans
Intensive Care Units
Machine Learning
Machine learning
Male
Mechanical intubation
Middle Aged
Predictive modeling
Respiration, Artificial
Risk Factors
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19
disease MESH complications
disease MESH nosocomial infections
disease MESH delirium
drug DRUGBANK Dextrose unspecified form
disease MESH Acute respiratory distress syndrome
drug DRUGBANK Saquinavir
drug DRUGBANK Nesiritide
drug DRUGBANK Coenzyme M
drug DRUGBANK Oxygen
disease MESH clinical relevance
disease IDO site
disease MESH weaning
drug DRUGBANK Magnesium
drug DRUGBANK Phosphorus
disease MESH myocardial infarction
disease MESH renal failure
disease MESH cardiac arrest
disease IDO history
disease IDO blood
drug DRUGBANK Aspartame
drug DRUGBANK Esomeprazole
disease MESH hypertension
disease MESH chronic kidney disease
drug DRUGBANK Urea
drug DRUGBANK Nitrogen
disease MESH Hyperlipidemia
disease MESH Asthma
pathway KEGG Asthma
drug DRUGBANK Lactic Acid
disease MESH Atrial Fibrillation
drug DRUGBANK Calcium
disease MESH Cerebrovascular Accident
disease MESH Cirrhosis
disease MESH Congestive Heart Failure
drug DRUGBANK Potassium
drug DRUGBANK Creatinine
disease MESH ESRD
disease MESH respiratory diseases
disease MESH Hyperglycemia
disease MESH insulin resistance
pathway KEGG Insulin resistance
disease MESH sepsis
disease MESH diabetes mellitus
disease MESH hyponatremia
disease MESH abnormalities
disease MESH infections
disease MESH secondary infection
disease IDO infection
disease MESH overweight
disease MESH bacterial pneumonia
disease MESH critically ill
disease IDO process
disease MESH causes
disease MESH Postintensive Care Syndrome
disease MESH respiratory failure
disease MESH bacterial infections
disease MESH tumor
disease MESH Lung Cancer
disease MESH pneumonia
disease MESH obesity paradox
disease MESH emergency
disease MESH clinical course
disease IDO algorithm
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)